In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway

R. Saranya

In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway - OOTY JSSCPO 2023 - 200

Dewey Class. No.: 615.5 SAR

In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway

APA

R. Saranya, Jubie.S, . (2023). In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway. OOTY: JSSCPO.

Chicago

R. Saranya, Jubie.S, . 2023. In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway. OOTY: JSSCPO.

Harvard

R. Saranya, Jubie.S, . (2023). In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway. OOTY: JSSCPO.

MLA

R. Saranya, Jubie.S, . In-Silico Design And Development Of Novel Hydroxyurea Lipid Drug Conjugates For Breast Cancer Therapy Targeting Pi3k/Akt/Mtor Pathway. OOTY: JSSCPO. 2023.

Place hold
Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core ISBD MARC (non-Unicode/MARC-8) MARCXML MODS (XML) RIS MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard)
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC